Point72 Asset Management
VINC

Point72 Asset Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Point72 Asset Management’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33,710
Closed -$483K – 2804
2024
Q3 		$483K Hold
33,710
– – ﹤0.01% 1617
2024
Q2 		$546K Sell
33,710
-14,031
-29% -$352K ﹤0.01% 1424
2024
Q1 		$4.83M Buy
47,741
+30,500
+177% +$1.93M 0.01% 973
2023
Q4 		$407K Hold
17,241
– – ﹤0.01% 1634
2023
Q3 		$348K Hold
17,241
– – ﹤0.01% 1619
2023
Q2 		$448K Sell
17,241
-25
-0.1% -$715 ﹤0.01% 1286
2023
Q1 		$359K Buy
17,266
+25
+0.1% +$560 ﹤0.01% 1318
2022
Q4 		$352K Hold
17,241
– – ﹤0.01% 1191
2022
Q3 		$476K Hold
17,241
– – ﹤0.01% 1175
2022
Q2 		$455K Hold
17,241
– – ﹤0.01% 1204
2022
Q1 		$1.38M Hold
17,241
– – 0.01% 927
2021
Q4 		$3.51M Hold
17,241
– – 0.02% 743
2021
Q3 		$5.14M Buy
+17,241
New +$5.03M 0.02% 656

Other funds holding VINC

SRC
Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return